Cargando…
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
BACKGROUND: There is currently no reliable serum biomarker for ovarian clear cell carcinoma (CCC), a highly lethal histological subtype of epithelial ovarian cancer (EOC). Previously, using a proteome-based approach, we identified tissue factor pathway inhibitor 2 (TFPI2) as a candidate serum biomar...
Autores principales: | Arakawa, Noriaki, Kobayashi, Hiroshi, Yonemoto, Naohiro, Masuishi, Yusuke, Ino, Yoko, Shigetomi, Hiroshi, Furukawa, Naoto, Ohtake, Norihisa, Miyagi, Yohei, Hirahara, Fumiki, Hirano, Hisashi, Miyagi, Etsuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087914/ https://www.ncbi.nlm.nih.gov/pubmed/27798689 http://dx.doi.org/10.1371/journal.pone.0165609 |
Ejemplares similares
-
Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells
por: Mogami, Tae, et al.
Publicado: (2013) -
Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
por: Ota, Yukihide, et al.
Publicado: (2021) -
Characterization of Matrix‐degrading Proteinases and Their Inhibitors Secreted by Human Gynecological Carcinoma Cells
por: Miyagi, Etsuko, et al.
Publicado: (1995) -
Data for identification of GPI-anchored peptides and ω-sites in cancer cell lines
por: Masuishi, Yusuke, et al.
Publicado: (2016) -
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
por: Miyagi, Etsuko, et al.
Publicado: (2021)